Skip to main content
WELL logo

WELL · Welltower Inc.

Track WELL — free
Market Cap
$166.33B
Shares
705.91M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$235.62 Open$236.92 Day$234.08–239.43 52W close$165.19–252.07 Avg vol 30d2.8M Short int18.4M · 2.6% float · 7.3d Short vol58% Last earningsJun 23, 2026 DataJan 2020–Sep 2026 Filing10-Q · Jul 28

Up next

filed Jul 28, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
Trailing 12 months
Net income (TTM)
Trailing 12 months
Revenue growth YoY
Year over year
Operating margin
Trailing 12 months
P / E (TTM)
Trailing earnings
FCF yield
TTM · current market cap
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Dividend yield
1.3%
Trailing 12 months
Shares change YoY
Year over year · more shares
Price change (1Y)
+39.9%
Trailing year
Short interest
2.6%
Latest settlement · 7.3 days to cover
View all 115 metrics

AI Brief

Q2 FY26 earnings call · Jun 23, 2026
Q2 FY26

TL;DR. Welltower reported a 25.0% YoY rise in normalized FFO per share to $1.60, with 20.5% SHO same-store NOI growth, and raised full-year normalized FFO guidance to $6.36–$6.44 per share while lowering net income guidance to $3.11–$3.19 per share. The Board also increased the quarterly dividend 15% to $0.85.

Bullish
  • + Normalized FFO per share rose 25.0% YoY to $1.60 in Q2
  • + Total SSNOI grew 15.5% YoY, led by SHO SSNOI growth of 20.5%
  • + Raised full-year normalized FFO guidance to $6.36–$6.44 per share from $6.21–$6.35
  • + Quarterly dividend increased 15% to $0.85, citing confidence in cash flow durability and balance sheet strength
  • + Strong SHO organic growth with 9.2% revenue growth, 330 bps occupancy growth and 5.2% RevPOR growth
  • + Year-to-date closed or under contract $15.5 billion of pro rata gross investments at attractive yields
Bearish
  • Lowered full-year net income attributable to common stockholders guidance to $3.11–$3.19 per share from $3.24–$3.38
  • Impairment of assets of $25.8 million in Q2

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Neutral Momentum Very Strong Sentiment Bullish Fundamentals Weak Quant / Vol Very Low
Market backdrop VIX 15.8 · calm Equity put/call 0.58
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +11%
above
Price vs 50-day avg −1%
below
RSI (14) 47
neutral
MACD trend Negative
52-week position 81%
mid-range
Momentum
relative strength
Very Strong
1-month return +1%
trailing
6-month return +20%
trailing
YTD return +27%
this year
Relative strength +2%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $238 › 200d $212 — 50d above 200d
Institutional flow Accumulating
+6% holders QoQ · +206 funds added
Insider flow Accumulating
Net +$2.4M over 90 days · 0% sells
Short interest Rising
2.61% of float · ▲ +3.7% MoM · 7.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
1,602 holders — near 3-yr high, broad support
Squeeze score 69
elevated · 0–100
Fundamentals
Weak
Revenue growth +36%
Y/Y
EPS growth −11%
Y/Y
Valuation P/E 117.2
rich
Buyback $3.0B
remaining
Balance sheet $14.2B
net debt
Quant / Vol
risk profile
Very Low
Volatility 23%
annualized · 1-yr
Max drawdown −13%
past year
ATR 2.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the 8-K filed Jul 27, 2026
Same Store NOI · full year 2026 Non-GAAP Initiated 13.75% – 16%
Seniors Housing Operating SSNOI · full year 2026 Non-GAAP Initiated 18.5% – 21.5%
Long-Term/Post-Acute Care SSNOI · full year 2026 Non-GAAP Initiated 2% – 3%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
1 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+11% Bullish
Price vs 50-day avg
−1% Neutral
RSI (14)
47 Neutral
MACD trend
Negative Bearish
52-week position
81% Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $238 › 200d $212 — 50d above 200d
Institutional flow Accumulating
+6% holders QoQ · +206 funds added
Insider flow Accumulating
Net +$2.4M over 90 days · 0% sells
Short interest Rising
2.61% of float · ▲ +3.7% MoM · 7.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
1,602 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $165 Now $236 · 81% Range high $252
vs 200-day avg +11% vs 50-day avg -1%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

REIT - Healthcare Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
WELL
Welltower Inc.
this stock
$166.33B +26.9% +35.6% 117.2 2.6%
VTR
Ventas, Inc.
$46.16B +16.3% +18.5% 166.7 4.0%
OHI
Omega Healthcare Investors Inc
$14.24B +6.0% +13.2% 16.7 4.3%
DOC
Healthpeak Properties, Inc.
$14.00B +26.2% +4.5% 58.0 3.5%
AHR
American Healthcare REIT, Inc.
$11.68B +13.9% +9.1% 77.7 9.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
1,602
% held
101.3%
Net QoQ
+38.3M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
1,026
View
Short & Settlement
Short Interest Rising
Shares short
18.4M
Days to cover
7.3d
Change
+652.5K sh
View
Short Volume
Short vol %
58%
As of
Sep 11, 2026
Short Total
View
Fails to Deliver
FTD shares
478
Value
$112.1K
As of
Aug 14, 2026
View
Off-Exchange
Off-exchange %
45.9%
Week of
Aug 3, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$2.4M
Buyers / Sellers
1 / 0
Buyers Sellers
View
Congressional Trades Buy
Member
Alan Armstrong
Amount
$1.0K–$15.0K
Traded
Mar 30, 2026
View
Financials
Financials
Revenue (FY)
$10.8B
Net income (FY)
$936.8M
EPS diluted
$1.39
View
Buybacks
Authorized
$3.0B
Remaining
$3.0B
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Jul 28, 2026
This year
13
View
Proposed Sales
Value
$605.4K
Shares
4.0K
Filed
Apr 30, 2025
View
Earnings & Events
Earnings Calls
Last call
Jun 23, 2026
View

Performance

5D 20D 120D MTD YTD
WELL -2.3% +0.5% +20.3% -0.3% +26.9%
SPY -1.2% -1.8% +17.8% -0.4% +12.1%
vs SPY -1.1% +2.3% +2.4% +0.1% +14.9%

Capital returns

Latest dividend
$0.85 / share · ex Aug 12, 2026
Raised 14.9%
Paid (TTM)
$3.07 / share · 4 payouts
Dividend yield (TTM, derived)
1.30%
Buyback program · as of Jun 30, 2026
Authorized
$3.00B
Spent (derived)
$0
Remaining
$3.00B
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 766704 CUSIP 95040Q104 13F (30d) 282 filings 264 filers Visit website Investor relations